C1 INH
Showing 1 - 25 of >10,000
End Stage Renal Disease, Chronic Kidney Diseases Trial in Los Angeles (Berinert, Placebo)
Active, not recruiting
- End Stage Renal Disease
- Chronic Kidney Diseases
- Berinert
- Placebo
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 5, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)
Recruiting
- Hereditary Angioedema
- HAE
- Dose 1 of BMN 331
- +4 more
-
Birmingham, Alabama
- +11 more
Jan 26, 2023
Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)
Available
- Hereditary Angioedema (HAE)
- Angioedema
- Lanadelumab 150 mg
- Lanadelumab 300 mg
-
Scottsdale, Arizona
- +19 more
Sep 16, 2022
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
-
San Diego, California
- +5 more
Jun 1, 2021
Graft Rejection Trial in Germany, United States (Placebo, C1 Esterase Inhibitor (Human))
Completed
- Graft Rejection
- Placebo
- C1 Esterase Inhibitor (Human)
-
Los Angeles, California
- +4 more
Jun 2, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
- Placebo (saline)
-
Scottsdale, Arizona
- +15 more
Jun 1, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
-
Scottsdale, Arizona
- +29 more
May 19, 2021
CVI - Common Variable Immunodeficiency Trial in Centennial (C1-esterase inhibitor [recombinant] (C1-INH-R))
Completed
- CVI - Common Variable Immunodeficiency
- C1-esterase inhibitor [recombinant] (C1-INH-R)
-
Centennial, ColoradoIMMUNOe Research Centers
Feb 11, 2021
Hereditary Angioedema Trial in United States (C1 inhibitor (human) [C1 INH])
Completed
- Hereditary Angioedema
- C1 inhibitor (human) [C1 INH]
-
Scottsdale, Arizona
- +10 more
Jun 17, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
-
Hoover, Alabama
- +47 more
May 19, 2021
Kidney Failure Trial (Placebo saline solution, Heparin, CINRYZE)
Not yet recruiting
- Kidney Failure
- Placebo saline solution
- +2 more
- (no location specified)
Oct 21, 2020
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
- Placebo (saline)
-
Hoover, Alabama
- +36 more
Jun 3, 2021
Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)
Recruiting
- Latent Tuberculosis Infection
- isoniazid and rifapentine
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2022
Treatment of Hereditary Angioedema (HAE) Attacks
Recruiting
- Hereditary Angioedema
- rhC1INH or pdC1INH
-
Sofia, Bulgaria
- +16 more
Sep 15, 2020
Genetic Variants in Hereditary Angioedema
Not yet recruiting
- Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
-
Barcelona, Spain
- +1 more
Apr 17, 2023
Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)
Antibody Mediated Rejection of Kidney Transplant Trial in New York (C1-INH (Berinert))
Completed
- Antibody Mediated Rejection of Kidney Transplant
- C1-INH (Berinert)
-
New York, New YorkNew York University School of Medicine
Jul 10, 2019
Teenagers and Non-histaminergic Angioedema With Normal C1
Not yet recruiting
- Hereditary Angioedema (HAE)
- Angioedema
- No Intervention
- (no location specified)
Jan 5, 2023
HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid
Completed
- HIV Infected Population With Latent Tuberculosis
- rifapentene (RPT)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 15, 2022
Kidney Failure Trial in Madison (rhC1INH, Saline Solution)
Unknown status
- Kidney Failure
- rhC1INH
- Saline Solution
-
Madison, WisconsinUniversity of Wisconsin
Dec 10, 2020
Tuberculosis Trial in Manaus, Rio De Janeiro (Rifapentine 600 mg and INH 300 mg, Rifapentine 900 mg and INH 900 mg)
Recruiting
- Tuberculosis
- Rifapentine 600 mg and INH 300 mg
- Rifapentine 900 mg and INH 900 mg
-
Manaus, AM, Brazil
- +1 more
Apr 14, 2022
Haemophilia A Trial in Berlin (NNC0365-3769 (Mim8))
Recruiting
- Haemophilia A
- NNC0365-3769 (Mim8)
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 24, 2023